Company profile: InaVein
1.1 - Company Overview
Company description
- Provider of innovative products to treat the full spectrum of vein disorders. Founded in 2007, InaVein develops and commercializes technologies including the TRIVEX System, which uses direct visualization to completely remove varicose veins in a shorter period of time compared to conventional phlebectomy procedures.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to InaVein
CV Ingenuity
HQ: United States
Website
- Description: Provider of drug-coated balloon platforms for the “Touch-and-Go” treatment of vascular diseases, developing devices to relieve vascular obstructions, inhibit restenosis, and enable natural vessel healing; Palo Alto, CA-based.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CV Ingenuity company profile →
Supira Medical
HQ: United States
Website
- Description: Provider of catheter-based circulatory support devices for heart conditions, including the Supira System, a percutaneous ventricular assist device for high-risk percutaneous coronary interventions and cardiogenic shock, featuring a low profile, high continuous flow, and sensors for real-time pressure measurements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Supira Medical company profile →
Bolt Medical
HQ: United States
Website
- Description: Provider of investigational medical devices for calcified arterial lesions, including Bolt IVLTM/Bolt IVL intravascular lithotripsy using laser-based acoustic pressure waves for coronary and peripheral arteries; RESTORE ATK/BTK systems for peripheral arterial disease above/below the knee; and the RESTORE FIH Coronary System, all under clinical evaluation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bolt Medical company profile →
SIS Medical
HQ: Switzerland
Website
- Description: Provider of vascular disease treatment products, developed, produced, and sold through its subsidiaries; founded in 2005 and headquartered in Winterthur, Switzerland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SIS Medical company profile →
Aegerion Pharmaceuticals
HQ: United States
Website
- Description: Provider of biopharmaceutical therapeutics to treat cardiovascular and metabolic diseases, focused on the development and commercialization of therapies, including lomitapide (AEGR-733), a microsomal triglyceride transfer protein inhibitor small molecule drug designed to decrease serum lipids.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aegerion Pharmaceuticals company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for InaVein
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to InaVein
2.2 - Growth funds investing in similar companies to InaVein
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for InaVein
4.2 - Public trading comparable groups for InaVein
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →